In the U.S. from 2014 to 2016, the rate of physician visits at which benzodiazepines were prescribed was highest among women aged 65 years and older, with 62 per 100 visits. In comparison, 9 percent of physician visits for 18 to 44 year-old males involved a benzodiazepine being prescribed. This statistic shows the physician visit rates at which benzodiazepines were prescribed among adults in the U.S. from 2014 to 2016, by age and gender.
Physician visit rates at which benzodiazepines were prescribed in the U.S. from 2014 to 2016, by age and gender (per 100 persons)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Visit rates for benzo and opioid prescriptions U.S. 2014-2016, by age and gender
- Basic Statistic Payment source for benzodiazepine prescription doctor visits U.S. 2014-2016, by age
- Basic Statistic Benzodiazepine prescription status during physician visits U.S. 2014-2016, by age
- Basic Statistic Diagnoses at physicians visits for benzodiazepines U.S. 2014-2016
- Basic Statistic Rate of mental or substance abuse hospitalization in the U.S. in 2016, by gender
- Premium Statistic Mean cost per substance-related U.S. hospitalization in 2016, by diagnosis
- Premium Statistic Cost per U.S. hospital stay for mental and substance use disorders in 2016
- Premium Statistic Cost per day in U.S. hospitals for mental and substance use disorders in 2016
- Premium Statistic Aggregate costs of substance-related U.S. hospitalizations in 2016, by diagnosis
- Basic Statistic Distribution of mental or substance abuse hospitalizations in the U.S. 2016, by age
About the region
10
- Premium Statistic Manufacture of synthetic opioids by type in the U.S. 2013-2022
- Basic Statistic Consumption of opium alkaloids and derivatives by type U.S. 2014-2022
- Basic Statistic Manufacture of opium alkaloids and derivatives by type U.S. 2013-2022
- Basic Statistic Number of veterans with opioid use disorder in the VHA U.S. 2015-2018
- Basic Statistic Number of persons with misuse of select Rx drug types in past month U.S. 2017
- Basic Statistic Number of persons misusing select Rx drug types in U.S. 2017, by gender
- Premium Statistic Rate of misuse of select prescription drug types in U.S. 2017, by age
- Premium Statistic U.S. substance use disorder-related delivery stays rate in 2016, by urbanicity
- Premium Statistic Clinical outcomes of substance use disorder-related delivery stays in the U.S. 2016
- Premium Statistic U.S. opioid use disorder market size from 2015 to 2026, by drug
Other regions
10
- Premium Statistic Number of users of sleeping and anxiety medicine in Denmark 2017, by type
- Basic Statistic Primary care doctors' ability to manage specialized care Canada 2019, by jurisdiction
- Premium Statistic Consumption rate of antidepressants in Italy 2022, by region
- Basic Statistic Number of users of melatonin in Norway 2009-2020 by gender
- Premium Statistic Manufacture of global synthetic opioids by type 2013-2022
- Premium Statistic Rate of users of sleep and sedative medication in Sweden 2009-2023
- Premium Statistic Amphetamine users in Croatia 2015, by age group
- Premium Statistic Number of persons misusing select Rx drug types in U.S. 2017, by age
- Premium Statistic Chile: frequency of visits with health specialists in 2018
- Premium Statistic Share of substance abusers among 15/16-year-olds in Iceland 1998-2017, by substance
Related statistics
10
- Basic Statistic Percentage of ED discharges with opioid prescriptions U.S. 2006-2017, by gender
- Premium Statistic Percentage of ED discharges with opioid prescriptions U.S. 2006 to 2017, by age
- Premium Statistic Average length of substance-related U.S. hospitalizations in 2016, by diagnosis
- Premium Statistic Rate of mental or substance abuse hospitalizations in the U.S. in 2016, by age
- Premium Statistic Cannabis consumption during the COVID-19 pandemic France 2020
- Premium Statistic U.S. emergency department visits for nonfatal cocaine overdoses, 2016-2017, by age
- Basic Statistic U.S. emergency department visit rates for nonfatal drug overdoses, 2016-2017, by age
- Basic Statistic U.S. emergency department visit rate for nonfatal opioid overdoses, 2016-2017, by age
- Basic Statistic U.S. emergency department visits for nonfatal heroin overdoses, 2016-2017, by age
- Basic Statistic Proportion of primary care physicians by weekly hours worked in select countries 2019
Further related statistics
10
- Number of worldwide users of cocaine by region 2010-2021
- Amphetamine users worldwide by region 2010-2020
- Number of cannabis users worldwide by region 2011-2021
- U.S. population without health care visits 1997-2018, by gender
- Mobile internet use via laptops in Great Britain 2019, by demographic
- Mental health and substance abuse services industry revenues in the U.S. 2008-2018
- Preventive care and screenings taken by adults aged 65 or older 2010
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Global revenue share of EssilorLuxottica in 2022, by geographical area
Further Content: You might find this interesting as well
Statistics
- Number of worldwide users of cocaine by region 2010-2021
- Amphetamine users worldwide by region 2010-2020
- Number of cannabis users worldwide by region 2011-2021
- U.S. population without health care visits 1997-2018, by gender
- Mobile internet use via laptops in Great Britain 2019, by demographic
- Mental health and substance abuse services industry revenues in the U.S. 2008-2018
- Preventive care and screenings taken by adults aged 65 or older 2010
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Global revenue share of EssilorLuxottica in 2022, by geographical area
NCHS, & CDC. (January 17, 2020). Physician visit rates at which benzodiazepines were prescribed in the U.S. from 2014 to 2016, by age and gender (per 100 persons) [Graph]. In Statista. Retrieved May 13, 2024, from https://www.statista.com/statistics/1095513/visit-rates-for-benzo-prescriptions-by-age-and-gender-us/
NCHS, und CDC. "Physician visit rates at which benzodiazepines were prescribed in the U.S. from 2014 to 2016, by age and gender (per 100 persons)." Chart. January 17, 2020. Statista. Accessed May 13, 2024. https://www.statista.com/statistics/1095513/visit-rates-for-benzo-prescriptions-by-age-and-gender-us/
NCHS, CDC. (2020). Physician visit rates at which benzodiazepines were prescribed in the U.S. from 2014 to 2016, by age and gender (per 100 persons). Statista. Statista Inc.. Accessed: May 13, 2024. https://www.statista.com/statistics/1095513/visit-rates-for-benzo-prescriptions-by-age-and-gender-us/
NCHS, and CDC. "Physician Visit Rates at Which Benzodiazepines Were Prescribed in The U.S. from 2014 to 2016, by Age and Gender (per 100 Persons)." Statista, Statista Inc., 17 Jan 2020, https://www.statista.com/statistics/1095513/visit-rates-for-benzo-prescriptions-by-age-and-gender-us/
NCHS & CDC, Physician visit rates at which benzodiazepines were prescribed in the U.S. from 2014 to 2016, by age and gender (per 100 persons) Statista, https://www.statista.com/statistics/1095513/visit-rates-for-benzo-prescriptions-by-age-and-gender-us/ (last visited May 13, 2024)
Physician visit rates at which benzodiazepines were prescribed in the U.S. from 2014 to 2016, by age and gender (per 100 persons) [Graph], NCHS, & CDC, January 17, 2020. [Online]. Available: https://www.statista.com/statistics/1095513/visit-rates-for-benzo-prescriptions-by-age-and-gender-us/